Credit: Getty Images. The approval was based on data from the phase 3 BUTTERFLEYE and FIREFLEYE trials. The Food and Drug Administration (FDA) has approved Eylea ® (aflibercept) for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback